← All drug classes
Drug class · FAERS comparison

Non-Standardized Chemical Allergen side effects compared: 4 drugs, 11,017 FDA adverse event reports

Class as assigned in the FDA label (Established Pharmacologic Class) · data 2026-09-14
How to read this page. Report counts are not incidence rates: a drug with more reports is usually older, more widely used or more publicised, not more dangerous. Signals are screened against each product's FDA label on its own page; a term flagged across most of a class usually reflects the shared mechanism or the shared patient population.

Members

DrugFAERS reportsSeriousDeath outcomeBoxed warningTop labeled signalsUnlabeled (unassessed)
Glycerin5,45471%598–––
Glycerin Suppositories (Glycerin)2,63993%374–––
Glycerin Suppository (Rite-Aid Glycerin Laxative)2,60093%368–––
Glycerine (Lemon Glycerine Swabsticks)32495%44–––

Class-wide signals (flagged in at least 2 of 4 members)

ReactionMembers flaggedMedian PRRReports (sum)In label
Macular degeneration4/4423.11,9210/4 members' labels
Vaginal discharge3/4123.74620/3 members' labels
Paraesthesia oral3/4119.06420/3 members' labels
Oral candidiasis3/497.14720/3 members' labels
Orthostatic hypotension3/475.84990/3 members' labels
Procedural pain3/456.45880/3 members' labels
Sedation3/447.54690/3 members' labels
Frequent bowel movements3/447.24800/3 members' labels
Colitis3/435.85200/3 members' labels
Depressed level of consciousness3/435.45320/3 members' labels
Rectal haemorrhage3/429.84890/3 members' labels
Colitis ulcerative3/428.44770/3 members' labels
Cognitive disorder3/428.35040/3 members' labels
Infusion related reaction3/425.86500/3 members' labels
Haematochezia3/424.35110/3 members' labels
Mobility decreased3/418.95190/3 members' labels
Bladder disorder3/416.8630/3 members' labels
Dyspepsia3/416.86330/3 members' labels
Constipation3/416.31,3930/3 members' labels
Balance disorder3/415.85380/3 members' labels
Pneumonia aspiration3/412.11240/3 members' labels
Ileus2/49.8300/2 members' labels
Anaemia2/49.74620/2 members' labels
Metastases to central nervous system2/49.7310/2 members' labels
Skin reaction2/49.7340/2 members' labels
Disseminated intravascular coagulation2/49.1320/2 members' labels
Urosepsis2/48.7200/2 members' labels
Abdominal pain2/48.54920/2 members' labels
Dementia2/48.2570/2 members' labels
Toxicity to various agents2/48.23420/2 members' labels

Member-specific signals (flagged in exactly one drug)

ReactionDrugReportsPRRLabel screen
Eye painGlycerin39727.8No label text to screen
Ocular discomfortGlycerin6824.2No label text to screen
Eye irritationGlycerin28519.7No label text to screen
PhotophobiaGlycerin8517.6No label text to screen
Lacrimation increasedGlycerin9712.5No label text to screen
Ocular hyperaemiaGlycerin13711.3No label text to screen
Dry eyeGlycerin13210.5No label text to screen
Eye swellingGlycerin778.0No label text to screen

Common questions

Which non-standardized chemical allergen has the most FDA adverse event reports?

Glycerin has the most FAERS co-reports in this class (5,454), followed by Glycerin Suppositories (2,639). Report volume tracks how widely and how long a drug has been used, and how much attention it has had, far more than its risk.

Which side effects are shared across non-standardized chemical allergen drugs?

Reaction terms flagged in at least half of the 4 members include macular degeneration, vaginal discharge, paraesthesia oral, oral candidiasis, orthostatic hypotension. A term shared across a class usually reflects the shared mechanism (or the shared patient population) rather than one product.

Does a FAERS signal mean the drug causes the reaction?

No. These are disproportionality signals from voluntary reports with no denominator. Each is screened against the FDA label (known vs unlabeled) on the drug pages; causality needs temporality, dose-response, plausibility and trial or cohort evidence.

Sources: openFDA FAERS pair statistics (OpenPV build 2026-09-14), FDA labels via openFDA, seriousness and death counts from openFDA count queries. Generated 2026-10-08. Not medical advice.